These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19200303)

  • 1. Immune thrombocytopenic purpura: the treatment paradigm.
    Stasi R
    Eur J Haematol Suppl; 2009 Mar; (71):13-9. PubMed ID: 19200303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of immune thrombocytopenic purpura in adults.
    Stasi R; Provan D
    Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
    Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
    Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura.
    Segel GB; Feig SA
    Pediatr Blood Cancer; 2009 Sep; 53(3):318-24. PubMed ID: 19165890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura.
    Buchanan GR; Adix L
    Semin Thromb Hemost; 2001 Jun; 27(3):277-85. PubMed ID: 11446661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of idiopathic thrombocytopenic purpura. American Society of Hematology ITP Practice Guideline Panel.
    Am Fam Physician; 1996 Dec; 54(8):2437-47, 2451-2. PubMed ID: 8961844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges in the management of children with idiopathic thrombocytopenic purpura.
    Buchanan GR; Adix L
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):681-4. PubMed ID: 16933253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults.
    George JN
    Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of immune thrombocytopenic purpura in children.
    Tarantino MD
    Curr Hematol Rep; 2006 Mar; 5(1):89-94. PubMed ID: 16537052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of immune thrombocytopenic purpura: a guide for clinical practice.
    Provan D
    Eur J Haematol Suppl; 2009 Mar; (71):8-12. PubMed ID: 19200302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
    Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B
    Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute immune thrombocytopenic purpura. To treat or not to treat?
    Bolton-Maggs P
    Hamostaseologie; 2009 Jan; 29(1):74-5. PubMed ID: 19151852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
    Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
    Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis.
    Ruggeri M; Fortuna S; Rodeghiero F
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):653-6. PubMed ID: 16933241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial management of adults with idiopathic (immune) thrombocytopenic purpura.
    George JN
    Blood Rev; 2002 Mar; 16(1):37-8. PubMed ID: 11913992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.